东北制药：江西方大钢铁集团有限公司累计质押股数约为1.95亿股

Group 1 - Northeast Pharmaceutical (SZ 000597) announced that as of the date of the announcement, Jiangxi Fangda Steel Group Co., Ltd. has pledged approximately 195 million shares, accounting for 42.6% of its holdings [1] - Liaoning Fangda Group has pledged a total of 48.74 million shares, representing 14.81% of its holdings [1] - As of the report date, Northeast Pharmaceutical's market capitalization is 8.2 billion yuan [1] Group 2 - For the first half of 2025, Northeast Pharmaceutical's revenue composition is as follows: pharmaceutical manufacturing accounts for 52.0%, pharmaceutical commerce accounts for 46.18%, and other industries account for 1.82% [1]